When Obviousness Isn’t Obvious: The Purdue Pharma v. Accord Decision

With the U.S. Supreme Court’s denial of certiorari in Purdue Pharma L.P. v. Accord Healthcare, Inc. (No. 24-1132), the Federal Circuit’s decision (No. 2023-1953, Dec. 30, 2024) now stands as controlling authority on the nexus requirement for objective indicia of non-obviousness. This CLE program takes a detailed look at Purdue’s litigation strategy from trial through appeal, unpacking how the company approached arguments on obviousness and secondary considerations. The discussion also... More Info